Mirum Pharmaceuticals (08D.XETRA) Q2 2026 Earnings

6MayConfirmed
Q2 2026
-11.43
-7.72
-4.02
-0.31

Details

Expected EPS
-0.310842217
Actual EPS
-11.42893
Surprise EPS
-11.12
Surprise Percent
+3,576.76%

Description

Mirum Pharmaceuticals (08D.XETRA) has reported earnings of -11.42893 per share for Q2 2026.

0 Comments

Share your thoughts